首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Heterogeneity of estrogen receptor a and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments
【24h】

Heterogeneity of estrogen receptor a and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments

机译:雌激素受体A和孕酮受体分布在未经处理的女性的深浸润子宫内膜异位症的病变中或暴露于各种荷尔蒙治疗期间

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Deep infiltrating endometriosis (DIE) responds variably to hormonal therapy. Mutations in cancer driver genes have been identified in a fraction of the ectopic endometrial epithelial cells, suggesting a functional heterogeneity of these lesions. To evaluate the phenotype heterogeneity of cells in DIE, we measured the expression of estrogen receptor a (ERa) and of progesterone receptor (PR) in DIE of untreated women or under various treatments. We analyzed the luminal epithelial height (LEH), immunoreactive epithelial staining (IRS) and stromal staining intensity (SSI) of ERa and PR. We observed a high variability in the same gland, among distinct glands in the same sample and among distinct patients receiving the same treatment. LEH variability was primarily due to epithelial cells heterogeneity in a gland, secondarily to the glands randomly evaluated on the same section, and tertiary to the patient category. Variability in IRS and SSI scores was primarily the consequence of their heterogeneity in the same woman and to a lesser extent to variability among patients. LEH and SSI were not modified according to treatment. IRS for PR was lower in treated patients. This heterogeneity of ERa and PR distribution could explain why endocrine treatments are unable to cure this condition.
机译:深浸润子宫内膜异位症(DIE)可变地响应荷尔蒙治疗。癌症驾驶员基因的突变已在异位子宫内膜上皮细胞的一部分中鉴定,表明这些病变的功能性异质性。为了评估模头中细胞的表型异质性,我们测量了未处理女性的雌激素受体A(时代)和孕酮受体(PR)的表达,或在各种治疗中。我们分析了时代和公关的腔上皮高度(LEH),免疫反应性上皮染色(IRS)和基质染色强度(SSI)。我们在同一样品中的不同腺体中观察到同一腺体中的高度变异性,并且在接受相同治疗的明显患者中存在具有明显的腺体。 leh变异性主要是由于腺体中的上皮细胞异质性,其次是随机评估的腺体在同一部分,以及患者类别的第三级。 IRS和SSI分数的可变性主要是它们在同一女性中的异质性并对患者之间的变异程度较小的结果。 LEH和SSI根据治疗没有修饰。治疗患者的PRS较低。这种时代和PR分布的异质性可以解释为什么内分泌治疗无法治愈这种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号